Scientists hunt for early warning signs of inherited nerve disease

NCT ID NCT07476365

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find early biological markers (biomarkers) for Charcot-Marie-Tooth disease type 1A (CMT1A), a common inherited nerve disorder. Researchers will analyze blood and nerve samples from 70 people aged 10-30 with CMT1A, along with animal models, to identify signs that predict how the disease will progress. The goal is to enable future clinical trials for treatments that could be given in childhood, before permanent nerve damage occurs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CMT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Medical Centre

    RECRUITING

    Göttingen, 37075, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.